Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |